Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
Holding AXSM?
Track your performance easily

Axsome Therapeutics (AXSM) Ownership - Who Owns Axsome Therapeutics?

1,885 Followers

Axsome Therapeutics (AXSM) Ownership Overview

0.50%18.33%1.32%13.05%66.80%
1.32% Other Institutional Investors
13.05% ETFs
66.80% Public Companies and Individual Investors
The ownership structure of Axsome Therapeutics (AXSM) stock is a mix of institutional, retail, and individual investors. Approximately 32.70% of the company’s stock is owned by Institutional Investors, 0.50% is owned by Insiders, and 66.80% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$13765
Jun 30, 2024
xxxxxxxxxxxxx
$25599885
Jun 30, 2024
xxxxxxxxxxxxx
$36958435

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,818,158Institution7.95%339,205,157
3,284,911Institution6.84%291,831,493
2,360,077Institution4.92%209,669,241
1,903,312Institution3.97%169,090,238
1,000,000Institution2.08%88,840,000
951,927Institution1.98%84,569,195
583,229Institution1.22%51,814,064
484,477Institution1.01%43,040,937
459,111Institution0.96%40,787,421
406,930Institution0.85%36,151,661

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,284,911Institution6.84%291,831,493
951,927Institution1.98%84,569,195
583,229Institution1.22%51,814,064
484,477Institution1.01%43,040,937
406,930Institution0.85%36,151,661
371,100Institution0.77%32,968,524
286,036Institution0.60%25,411,438
220,231Institution0.46%19,565,322
217,389Institution0.45%19,312,839
185,025Institution0.39%16,437,621

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,310,003Institution2.73%117,729,970
1,020,976Institution2.13%91,755,113
938,425Institution1.96%83,369,677
609,426Institution1.27%54,769,115
563,226Institution1.17%50,617,121
325,371Institution0.68%28,905,960
274,993Institution0.57%24,430,378
194,454Institution0.41%17,312,240
167,071Institution0.35%15,014,671
102,419Institution0.21%9,204,396

FAQ

Who Owns Axsome Therapeutics Inc (AXSM)?
According to the latest TipRanks data, approximately 1.32% of the company's stock is held by institutional investors, 0.50% is held by insiders, and 66.80% is held by retail investors.
    What percentage of Axsome Therapeutics Inc (AXSM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.32% of Axsome Therapeutics Inc (AXSM) stock is held by institutional investors.
      What percentage of Axsome Therapeutics Inc (AXSM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 66.80% of Axsome Therapeutics Inc (AXSM) stock is held by retail investors.
        Who owns the most shares of Axsome Therapeutics Inc (AXSM)?
        Vanguard owns the most shares of Axsome Therapeutics Inc (AXSM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis